Hydrolysis of cis- and trans-epoxyeicosatrienoic acids by rat red blood cells. - Wikidata - wikimedia - TriplyDB

Hydrolysis of cis- and trans-epoxyeicosatrienoic acids by rat red blood cells.

Hydrolysis of cis- and trans-epoxyeicosatrienoic acids by rat red blood cells.

http://www.wikidata.org/entity/Q37319310

about

Soluble epoxide hydrolase: gene structure, expression and deletion Method for Sorting and Pairwise Selection of Nanobodies for the Development of Highly Sensitive Sandwich Immunoassays Epoxides and soluble epoxide hydrolase in cardiovascular physiology Roles of CYP2C29 and RXR gamma in vascular EET synthesis of female mice Increase of EPA-derived hydroxy, epoxy and dihydroxy fatty acid levels in human plasma after a single dose of long-chain omega-3 PUFA.High potassium intake enhances the inhibitory effect of 11,12-EET on ENaC.Role of soluble epoxide hydrolase in age-related vascular cognitive decline.Soluble epoxide hydrolase as an anti-inflammatory target of the thrombolytic stroke drug SMTP-7 Identification of 13-hydroxy-14,15-epoxyeicosatrienoic acid as an acid-stable endothelium-derived hyperpolarizing factor in rabbit arteries.Increases in plasma trans-EETs and blood pressure reduction in spontaneously hypertensive rats.The red blood cell participates in regulation of the circulation by producing and releasing epoxyeicosatrienoic acids Maternal and fetal epoxyeicosatrienoic acids in normotensive and preeclamptic pregnancies.Vitamin C activation of the biosynthesis of epoxyeicosatrienoic acids.Influence of inflammation on cardiovascular protective effects of cytochrome P450 epoxygenase-derived epoxyeicosatrienoic acids.Enzymatic and free radical formation of cis- and trans- epoxyeicosatrienoic acids in vitro and in vivo.Cytochrome P450 eicosanoids in cerebrovascular function and disease.Steric analysis of epoxyalcohol and trihydroxy derivatives of 9-hydroperoxy-linoleic acid from hematin and enzymatic synthesis.Catalytic activities of mammalian epoxide hydrolases with cis and trans fatty acid epoxides relevant to skin barrier function.GPR40 is a Low Affinity Epoxyeicosatrienoic Acid Receptor in Vascular Cells.

P2860

Q28291292-DB03745B-FC05-4D29-87CA-EDA4A6678A58 Q28395341-D361F7F7-9094-4458-93D6-F3E2CA288726 Q28396313-9DBD2BCE-A9F1-4C3D-AD89-BF05E570E612 Q33784363-DD06644A-ACB0-4556-8DE5-E5682B4DC902 Q34231280-818B07CC-41B3-43F2-A63E-F9C4DFA36B38 Q34455448-FF07DC39-9231-4C3C-8FBA-0A46090EBF0F Q34622501-7502D853-DA86-46FF-AAA4-23F315F6A060 Q34774458-083A5B58-84E9-4848-90C2-784E7BC50C97 Q35001637-D0793258-F746-496D-8472-AF2267636ADA Q35056911-853F00B4-D2AC-4A9B-8D50-FF3AC80A109E Q35984991-96B0D74A-5D4F-418E-BDA3-7F7F49D83D25 Q37603623-12215481-851D-4804-AF7F-F4D1E567FE7A Q37645559-040BBC6F-D8DD-4B17-ADCD-5784F8B69BC6 Q38138158-2DB1C5AF-45BC-4F40-B8A1-CAF57260EB92 Q38653286-B451E69B-63EE-42B5-9372-4D67C8124BE5 Q39319956-3C4B9A51-AF7B-49D2-A539-404A06CF696D Q41862175-040BB6AB-37B2-499D-80B5-A5FA1D7DDB31 Q49832279-BF368D51-CE48-4AEA-B165-AD683692539C Q54978759-051920B9-B6A7-4B97-A011-A60CE38CED20

P2860

Hydrolysis of cis- and trans-epoxyeicosatrienoic acids by rat red blood cells.

http://www.wikidata.org/entity/Q37319310

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 29 April 2008

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Hydrolysis of cis- and trans-epoxyeicosatrienoic acids by rat red blood cells.

@en

Hydrolysis of cis- and trans-epoxyeicosatrienoic acids by rat red blood cells.

@nl

type

label

Hydrolysis of cis- and trans-epoxyeicosatrienoic acids by rat red blood cells.

@en

Hydrolysis of cis- and trans-epoxyeicosatrienoic acids by rat red blood cells.

@nl

prefLabel

Hydrolysis of cis- and trans-epoxyeicosatrienoic acids by rat red blood cells.

@en

Hydrolysis of cis- and trans-epoxyeicosatrienoic acids by rat red blood cells.

@nl

P1433

Q37319310-6D61322A-6500-4F0D-9BC5-196C4CC5ACF3

P1476

Q37319310-1641F139-8A33-49D1-A537-89F829698873

P2093

Q37319310-511D3877-D248-4792-A853-8337E0D2EBFE

Q37319310-5DF972BD-ACEF-46A2-BFED-730418209E75

Q37319310-71401334-60DA-4650-A5D5-6173572D07E8

Q37319310-8B214577-F908-45CF-A59E-86DCD0F67774

Q37319310-901A974F-13FB-4E26-A66B-A2B7A6080F79

Q37319310-C6443371-0C24-4EF5-BCA4-EF25BDC96387

Q37319310-F2150BCB-7251-493A-B0C8-0917F30E2A91

P2860

Q37319310-052A528F-47D5-473E-A79D-5B52C0A49207

Q37319310-09593FDB-32E6-4621-AB43-E8065BD85AE3

Q37319310-15A54B5B-8E4A-42A8-B9AE-F8F31DE0CCCD

Q37319310-17C39F8A-641F-49AC-ACDE-F550E9AD5054

Q37319310-225230AB-81AD-49D4-A029-9BD16A223DCF

Q37319310-322353E8-C050-485B-BA94-FBA0E50EB9B1

Q37319310-32C13CB6-D982-4C3B-B85D-119B6A389612

Q37319310-4AC2E8F3-7F8B-456F-8E49-28FC61709D12

Q37319310-50580A8F-3E7F-4BD8-BAFE-C567744DB95A

Q37319310-54E542D5-068E-4486-8E32-403C674CA5FE

P304

Q37319310-2E20A2DE-7468-4350-A928-4E7EB910AA40

P31

Q37319310-E7302F99-FFF6-4D1E-BF3C-0C8546EBF031

P356

Q37319310-6DDA4682-08E4-4941-8699-9AAA89E1679E

P407

Q37319310-A679A435-D5C7-4833-AB93-D2E397993BBA

P433

Q37319310-F4597CA6-BBFF-46CF-A82B-54F439349935

P478

Q37319310-880BFFD8-6F0E-4FA2-A0BD-48844BBE8B24

P577

Q37319310-ABCAA73A-2394-4FC6-8850-6797D962A1F9

P5875

Q37319310-37BFBDB7-EF5F-4785-B611-4F9151E1C45C

P698

Q37319310-FFD43E7B-74DB-4475-8C81-0AAA197F044F

P932

Q37319310-9ACCF639-BC91-40E2-98BE-CC4DF38FC519

P356

JPET.107.134858

P1433

Journal of Pharmacology and Experimental Therapeutics

P1476

Hydrolysis of cis- and trans-epoxyeicosatrienoic acids by rat red blood cells.

@en

P2093

Angela G Zhu

http://www.w3.org/2001/XMLSchema#string

Bruce D Hammock

http://www.w3.org/2001/XMLSchema#string

Christophe Morisseau

http://www.w3.org/2001/XMLSchema#string

Houli Jiang

http://www.w3.org/2001/XMLSchema#string

John C McGiff

http://www.w3.org/2001/XMLSchema#string

John R Falck

http://www.w3.org/2001/XMLSchema#string

Magdalena Mamczur

http://www.w3.org/2001/XMLSchema#string

P2860

Epoxide hydrolases: mechanisms, inhibitor designs, and biological roles

Soluble epoxide hydrolase: a novel therapeutic target in stroke

Role of soluble epoxide hydrolase in postischemic recovery of heart contractile function

Attenuation of tobacco smoke-induced lung inflammation by treatment with a soluble epoxide hydrolase inhibitor

Soluble epoxide hydrolase inhibition lowers arterial blood pressure in angiotensin II hypertension

Enzymatic hydration of leukotriene A4. Purification and characterization of a novel epoxide hydrolase from human erythrocytes

Targeted disruption of soluble epoxide hydrolase reveals a role in blood pressure regulation

Soluble epoxide hydrolase is a therapeutic target for acute inflammation

Inhibitors of soluble epoxide hydrolase attenuate vascular smooth muscle cell proliferation.

The antiinflammatory effect of laminar flow: the role of PPARgamma, epoxyeicosatrienoic acids, and soluble epoxide hydrolase

P304

330-337

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1124/JPET.107.134858

http://www.w3.org/2001/XMLSchema#string

P407

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

326

http://www.w3.org/2001/XMLSchema#string

P577

2008-04-29T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

5406247

http://www.w3.org/2001/XMLSchema#string

P698

18445784

http://www.w3.org/2001/XMLSchema#string

P932

2732189

http://www.w3.org/2001/XMLSchema#string